{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T03:53:38Z","timestamp":1777348418807,"version":"3.51.4"},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:p>Recognizing the increasing threat of transfusion\u2010transmitted babesiosis to the US blood supply, the AABB Board of Directors tasked an Ad Hoc <jats:italic>Babesia<\/jats:italic> Policy Working Group (the Working Group) to use the Alliance of Blood Operators' risk\u2010based decision\u2010making (RBDM) framework to assess the risks and benefits of introducing <jats:italic>Babesia<\/jats:italic> donation testing in the United States. The regional nature of the <jats:italic>Babesia microti<\/jats:italic> risk added complexity to the RBDM assessment because of the unique operational and financial considerations for operators and hospitals located in endemic states. Therefore, the assessment considered safety, product availability, sector sustainability, and technology availability.<\/jats:p><jats:p>After assessing safety risk, economic and operational impact, reimbursement equity, ethical considerations, and stakeholder feedback from two consultations, the Working Group concluded that a regional approach to donor screening in endemic states was appropriate because it applied the intervention where the risk was highest and appropriately allocated cost to the risk. Nucleic acid testing using a ribosomal RNA template was the recommended intervention because it was the most cost\u2010effective, resulted in no wasted units, and captured similar numbers of infections as antibody plus DNA\u2010based polymerase chain reaction. The current model for blood reimbursement was maintained but AABB was encouraged to facilitate collection of data to identify threats to sector sustainability in endemic states. <jats:italic>Babesia<\/jats:italic> expansion was acknowledged with a mechanism to regularly reevaluate what are \u201cendemic states.\u201d Finally, given that public awareness of the <jats:italic>Babesia<\/jats:italic> threat is the first line of defense, AABB should work with appropriate agencies for general education about the health risk from <jats:italic>B. microti<\/jats:italic>.<\/jats:p>","DOI":"10.1111\/trf.14912","type":"journal-article","created":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T17:42:53Z","timestamp":1536082973000},"page":"1916-1923","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Assessing the risk of <i>Babesia<\/i> to the United States blood supply using a risk\u2010based decision\u2010making approach: Report of AABB's Ad Hoc <i>Babesia<\/i> Policy Working Group (original report)"],"prefix":"10.1111","volume":"58","author":[{"given":"Sheila J.","family":"Ward","sequence":"first","affiliation":[{"name":"Canadian Blood Services  Ottawa Ontario Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[{"name":"Scientific Affairs American Red Cross  Gaithersburg Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2357-9564","authenticated-orcid":false,"given":"Zbigniew M.","family":"Szczepiorkowski","sequence":"additional","affiliation":[{"name":"Department of Pathology Dartmouth\u2010Hitchcock Medical Center  Lebanon New Hampshire"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,9,4]]},"reference":[{"key":"e_1_2_14_2_1","unstructured":"Alliance of Blood Operators [Internet].2014[cited 2018 May 14]. Available from:https:\/\/www.allianceofbloodoperators.org\/home.aspx."},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2011.01526.x"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00362"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14476"},{"key":"e_1_2_14_6_1","volume-title":"Annual summary for fiscal year 2014","year":"2018"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600897"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2016.04.002"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14518"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14655"},{"key":"e_1_2_14_11_1","volume-title":"Babesiosis. AABB Association Bulletin #14\u201005","author":"Sher G","year":"2014"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14103"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13136"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12805"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12492"},{"key":"e_1_2_14_16_1","volume-title":"The 2013 AABB blood colletion, utilization, and patient blood management survey report [Internet]","author":"Whitaker BI","year":"2015"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13618"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/voxs.12169"},{"key":"e_1_2_14_19_1","volume-title":"FDA News Release March 6, 2018 [Internet]","year":"2018"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.14912","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.14912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T03:53:42Z","timestamp":1695009222000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.14912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1111\/trf.14912"],"URL":"https:\/\/doi.org\/10.1111\/trf.14912","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"2018-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}